Avidity Partners Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-106,000
Closed -$18.7M 66
2025
Q2
$18.7M Buy
106,000
+34,000
+47% +$5.12M 3.72% 6
2025
Q1
$9.68M Sell
72,000
-65,000
-47% -$8.56M 1.85% 17
2024
Q4
$17.3M Sell
137,000
-116,000
-46% -$17.2M 1.7% 25
2024
Q3
$42M Sell
253,000
-119,000
-32% -$18M 2.15% 16
2024
Q2
$49.5M Sell
372,000
-229,000
-38% -$27.6M 2.1% 15
2024
Q1
$63.2M Sell
601,000
-270,000
-31% -$24.3M 2.04% 17
2023
Q4
$65.8M Sell
871,000
-92,800
-10% -$5.88M 2.4% 10
2023
Q3
$63.5M Sell
963,800
-26,700
-3% -$2M 2.56% 7
2023
Q2
$80.6M Sell
990,500
-481,500
-33% -$34.3M 2.82% 5
2023
Q1
$87.5M Buy
1,472,000
+754,700
+105% +$41.9M 2.9% 8
2022
Q4
$35M Buy
+717,300
New +$33.2M 0.76% 40

Other funds holding THC

Avidity Partners Management's THC Position: Q3 2025 in Review

Avidity Partners Management sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 106,000 shares — an estimated $18.7M sold.

Avidity Partners Management first reported a position in THC in Q4 2022 and held it in 11 quarters. The position peaked at $87.5M in Q1 2023. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Avidity Partners Management reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Avidity Partners Management sold 106,000 Tenet Healthcare shares in Q3 2025, an estimated $18.7M.
  • Avidity Partners Management first reported a position in Tenet Healthcare in Q4 2022 and held it in 11 quarters.
  • Avidity Partners Management's Tenet Healthcare position peaked at $87.5M in Q1 2023.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Avidity Partners Management's 13F filing for Q3 2025, filed 14 Nov 2025.